HNDFDS

- Hindustan Foods Limited has been voluntarily assigned an ESG rating of '59' (Adequate) by Crisil ESG Ratings & Analytics Limited for FY 2025-26. - The rating was independently determined based on public disclosures and information without direct engagement by the company.

- Trading window closed from October 1, 2026. - Closure remains effective until 48 hours after declaration of Q2 and H1 financial results ended September 30, 2026. - Board meeting date to approve results will be intimated in due course.

- Board meeting held on September 23, 2026. - Accepted resignation of Mr. Nikhil Vora as Non-Executive, Non-Independent Director. - Mr. Shashi Kalathil re-designated from Independent Director to Non-Executive, Non-Independent Director after completing his 2nd term, continuing as Chairman. - Re-constitution of the Audit Committee and Nomination and Remuneration Committee.

- The Board accepted the resignation of Mr. Nikhil Vora as Non-Executive, Non-Independent Director due to increased professional responsibilities and commitments, effective September 23, 2026. - Mr. Shashi Kalathil's designation changed from Independent Director to Non-Executive, Non-Independent Director, upon completion of his 2nd term as ID, effective September 23, 2026. He will continue to serve as the Chairman. - The Audit Committee and Nomination and Remuneration Committee were reconstituted.

- Resignation of Mr. Nikhil Vora as Non-Executive, Non-Independent Director effective September 23, 2026, due to increased professional responsibilities. - Mr. Shashi Kalathil's designation changed from Independent Director to Non-Executive, Non-Independent Director, effective September 23, 2026, upon completion of his 2nd term. He will continue as Chairman, Non-Executive Non-Independent Director. - Re-constitution of the Audit Committee and Nomination and Remuneration Committee.

- Hindustan Foods' Nomination and Remuneration Committee met on September 18, 2026. - It allotted 1,46,300 Equity Shares and granted 1,05,900 fresh Employee Stock Options under HFL ESOS 2025, with an exercise price of Rs. 2 per option. - This increases the paid-up share capital from INR 24.23 Cr to INR 24.26 Cr.

- Nomination and Remuneration Committee meeting held on September 18, 2026. - Approved allotment of 1,46,300 Equity Shares to eligible employees under HFL ESOS 2025. - Approved grant of 1,05,900 fresh Employee Stock Options under HFL ESOS 2025 to eligible employees at an exercise price of ₹2 per option.

- Investor Meeting Schedule - Meeting 1: September 8, 2026, 9:00 am onwards with Nuvama Institutional Equities in Mumbai. - Meeting 2: September 15, 2026, 9:00 am onwards with Nuvama Institutional Equities in Mumbai.

- Hindustan Foods Limited officials will participate in Non-Deal Roadshows (NDR) to meet investors. - Scheduled Dates: - September 8, 2026, from 9:00 am onwards, 1x1 / Group Meeting in Mumbai, organized by Nuvama Institutional Equities. - September 15, 2026, from 9:00 am onwards, 1x1 / Group Meeting in Mumbai, organized by Nuvama Institutional Equities.

- Concall Schedule - Concall Date: September 7, 2026 - Concall Time: 04:00 pm onwards - Type: Group Meeting (In-person)

- Notice of the 41st Annual General Meeting (AGM) for FY 2025-26. - AGM to be held on Wednesday, September 23, 2026, at 11:30 A.M. (IST) via Video Conferencing/OAVM. - Web-links for the Annual Report are also provided.

- Concall Schedule - Concall Date: August 31, 2026 - Concall Time: 02:30 pm Onwards - Meeting Type: Group Meeting with Analysts/Institutional Investors - Mode/Place: In-person at Mumbai

- Investor Meeting Schedule - Meeting Date: August 28, 2026 - Meeting Time: 04:00 pm onwards - Mode: In-person at Mumbai

- The Securities Appellate Tribunal (SAT) dismissed Hindustan Foods Limited's appeal against a fine of ₹52,21,500 imposed by BSE for SEBI (LODR) Regulations violation. - The company states no material financial impact and is in the process of contesting the said Order.

- Reaffirmed FY '27 PAT guidance of INR200-220 crores (34%-48% growth YoY). - Expects to commercialize manufacturing capacities exceeding INR500 crores during FY '27. - Project pipeline of approximately INR1,000 crores indicates strong future growth opportunities. - Acknowledged temporary cost pressures in the footwear business (INR6 Cr impact in Q1 FY27) and a temporary disruption at the Silvassa facility, with mitigation strategies in place. - Continues to leverage internal accruals to maintain a 1:1 debt-equity ratio and fund growth.

- Submission of audio recording for the Analyst/Investors conference call held on August 05, 2026. - The call discussed the company's performance for the Quarter ended June 30, 2026. - The recording is available on the company's website at https://www.hindustanfoodslimited.com/investor-presentation.php.

- Consolidated Total Income ₹1,207.0 Cr vs ₹1,022.2 Cr (▲18% YoY) - EBITDA ₹106.3 Cr vs ₹84.3 Cr (▲26% YoY) - PAT ₹42.8 Cr vs ₹32.2 Cr (▲33% YoY) - EBITDA Margin 8.8% vs 8.3% (▲55bps) - Board authorized additional investments of ₹190 Cr, bringing total FY27 projects to ₹340 Cr. - Reaffirms FY27 PAT guidance of ₹200-220 Cr.

- Hindustan Foods Limited submitted the Monitoring Agency Report for Q1 FY27 (June 30, 2026) regarding the preferential issue of convertible warrants. - The company revised the total cost of objects to ₹377.50 Cr from ₹399.99 Cr due to cancellation of 5,32,009 warrants (non-exercise of conversion option) by one investor, leading to a reduction of ₹22.50 Cr (5.6%) in gross proceeds. The Monitoring Agency noted this reduction "may impact the viability of the objects." - Funds utilized in Q1 FY27 were as per the specified objects and revised costs; ₹5.03 Cr was utilized for the acquisition of M/s. Ultra Beauty Care Private Limited's business undertaking. - ₹43.53 Cr of unutilized funds are primarily held in fixed deposits. - No delays were reported in the implementation of the object for inorganic growth opportunities and strategic acquisition.

- Consolidated Revenue ₹1,201.08 Cr vs ₹1,018.69 Cr (▲17.90% YoY) - EBITDA ₹100.25 Cr vs ₹80.79 Cr (▲24.09% YoY) - PAT ₹42.76 Cr vs ₹32.21 Cr (▲32.76% YoY) - EBITDA Margin 8.35% vs 7.93% (▲42bps)